Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cappellini

Showing results (831-840 of 863) with videos related to

Pageof 87
Sort By:
Frontiers in Immunology|April 28, 2017
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup StudyPaola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone LymphomaStephen Opat, Alessandra Tedeschi, Kim Linton, et al.
Respiratory Medicine|October 30, 2021
Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up studyLorenzo Gamberini, Carlo Alberto Mazzoli, Irene Prediletto, et al.
Frontiers in Immunology|March 14, 2018
Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup StudyPaola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 12, 2021
Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-upLorenzo Gamberini, Carlo Alberto Mazzoli, Harri Sintonen, et al.
Lancet (London, England)|June 22, 2025
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trialAli T Taher, Hanny Al-Samkari, Yesim Aydinok, et al.
Annals of Intensive Care|April 26, 2021
Sustained oxygenation improvement after first prone positioning is associated with liberation from mechanical ventilation and mortality in critically ill COVID-19 patients: a cohort studyGaetano Scaramuzzo, Lorenzo Gamberini, Tommaso Tonetti, et al.
European Journal of Nutrition|December 23, 2016
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT StudyM Vitale, M Masulli, A A Rivellese, et al.
Science (New York, N.Y.)|July 7, 2007
Ancient biomolecules from deep ice cores reveal a forested southern GreenlandEske Willerslev, Enrico Cappellini, Wouter Boomsma, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2023
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma IntergroupMarco Rubatto, Paolo Fava, Ignazio Stanganelli, et al.
Pageof 87

Showing results (831-840 of 863) with videos related to

Sort By:
Pageof 87
Frontiers in Immunology|April 28, 2017
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup StudyPaola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone LymphomaStephen Opat, Alessandra Tedeschi, Kim Linton, et al.
Respiratory Medicine|October 30, 2021
Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up studyLorenzo Gamberini, Carlo Alberto Mazzoli, Irene Prediletto, et al.
Frontiers in Immunology|March 14, 2018
Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup StudyPaola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 12, 2021
Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-upLorenzo Gamberini, Carlo Alberto Mazzoli, Harri Sintonen, et al.
Lancet (London, England)|June 22, 2025
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trialAli T Taher, Hanny Al-Samkari, Yesim Aydinok, et al.
Annals of Intensive Care|April 26, 2021
Sustained oxygenation improvement after first prone positioning is associated with liberation from mechanical ventilation and mortality in critically ill COVID-19 patients: a cohort studyGaetano Scaramuzzo, Lorenzo Gamberini, Tommaso Tonetti, et al.
European Journal of Nutrition|December 23, 2016
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT StudyM Vitale, M Masulli, A A Rivellese, et al.
Science (New York, N.Y.)|July 7, 2007
Ancient biomolecules from deep ice cores reveal a forested southern GreenlandEske Willerslev, Enrico Cappellini, Wouter Boomsma, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2023
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma IntergroupMarco Rubatto, Paolo Fava, Ignazio Stanganelli, et al.
Pageof 87